Sudden dysphagia with uvular enlargement following the initiation of risperidone which responded to benztropine: was this an extrapyramidal side effect?
Nair
S
S
Saeed
O
O
Shahab
H
H
Sedky
K
K
Garver
D
D
Lippmann
S
S
D000328:Adult; D000978:Antiparkinson Agents / Q000627:therapeutic use*; D014150:Antipsychotic Agents / Q000009:adverse effects*; D001480:Basal Ganglia Diseases / Q000139:chemically induced* / Q000175:diagnosis; D001590:Benztropine / Q000627:therapeutic use*; D003680:Deglutition Disorders / Q000139:chemically induced*; D006801:Humans; D008297:Male; D010608:Pharyngeal Diseases / Q000139:chemically induced / Q000188:drug therapy / Q000503:physiopathology; D018967:Risperidone / Q000009:adverse effects*; D012559:Schizophrenia / Q000188:drug therapy; D014609:Uvula / Q000187:drug effects* / Q000503:physiopathology*
D000978:Antiparkinson Agents; D014150:Antipsychotic Agents; D001590:Benztropine; D018967:Risperidone